Literature DB >> 3356486

Family history of colorectal cancer as a risk factor for benign and malignant tumours of the large bowel. A case-control study.

L Bonelli1, H Martines, M Conio, P Bruzzi, H Aste.   

Abstract

The relationship between first degree family history of colorectal cancer and the risk of benign or malignant tumours of the large bowel was investigated in a case-control study. Two groups of cases (283 patients with adenomatous polyps and 414 patients with adenocarcinoma of the large bowel) and 2 groups of controls (399 polyp-free subjects and 456 hospitalized patients) were interviewed. Since no difference in the frequency of family history between the 2 control groups was detected, these were lumped together. A 3-fold increase in risk of adenomatous polyps in relatives of patients with colon cancer was observed (OR = 3.18, 95% CI 2.06-4.89). The relative risk of colorectal cancer among relatives of patients with adenocarcinoma was 2.36 (95% CI 1.54-3.60). No significant difference in the frequency of first degree relatives with a history of cancer of the large bowel was detected between patients with colorectal cancer and those with adenomatous polyps. When only history of colorectal cancer among parents was considered, the results closely paralleled those of the previous analysis.

Entities:  

Mesh:

Year:  1988        PMID: 3356486     DOI: 10.1002/ijc.2910410407

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  28 in total

1.  Unfavorable effect of small tumor size on cause-specific survival in stage IIA colon cancer, a SEER-based study.

Authors:  Yuwei Wang; Changhua Zhuo; Debing Shi; Hongtu Zheng; Ye Xu; Weilie Gu; Sanjun Cai; Guoxiang Cai
Journal:  Int J Colorectal Dis       Date:  2014-11-13       Impact factor: 2.571

2.  Guidance on large bowel surveillance for people with two first degree relatives with colorectal cancer or one first degree relative diagnosed with colorectal cancer under 45 years.

Authors:  M G Dunlop
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

3.  Association between family history and mismatch repair in colorectal cancer.

Authors:  R P Coggins; L Cawkwell; S M Bell; G P Crockford; P Quirke; P J Finan; D T Bishop
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

4.  Risk of colorectal adenomas in patients with a family history of colorectal cancer: some implications for screening programmes.

Authors:  J F Aitken; C J Bain; M Ward; V Siskind; R MacLennan
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

5.  Impact of a family history of colorectal cancer on the prevalence of advanced adenomas of the rectosigmoid colon at flexible sigmoidoscopy in 3147 asymptomatic patients.

Authors:  Williamson B Strum
Journal:  Dig Dis Sci       Date:  2006-11       Impact factor: 3.199

6.  Prevention of colorectal cancer: guidelines based on new data. WHO Collaborating Center for the Prevention of Colorectal Cancer.

Authors:  S J Winawer; D J St John; J H Bond; P Rozen; R W Burt; J D Waye; O Kronborg; M J O'Brien; D T Bishop; R C Kurtz
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

Review 7.  Epidemiology and management options for colorectal cancer in children.

Authors:  Raya Saab; Wayne L Furman
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

8.  The correlation between a family history of colorectal cancer and survival of patients with colorectal cancer.

Authors:  Helgi Birgisson; Arezo Ghanipour; Kennet Smedh; Lars Påhlman; Bengt Glimelius
Journal:  Fam Cancer       Date:  2009       Impact factor: 2.375

9.  Familial risk of colo-rectal cancer in a low incidence area in southern Italy.

Authors:  S Centonze; H Boeing; C Leoci; C Bonfiglio; V Guerra; G Misciagna
Journal:  Eur J Epidemiol       Date:  1993-01       Impact factor: 8.082

Review 10.  Diagnostic accuracy systematic review of rectal bleeding in combination with other symptoms, signs and tests in relation to colorectal cancer.

Authors:  M Olde Bekkink; C McCowan; G A Falk; C Teljeur; F A Van de Laar; T Fahey
Journal:  Br J Cancer       Date:  2009-11-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.